Paclitaxel Vitamin E-Based Emulsion clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How each study uses Paclitaxel Vitamin E-Based Emulsion is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- S-8184 Paclitaxel Injectable Emulsion
- 4
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic agents source
Studies
Open first, then newest update. How each study uses Paclitaxel Vitamin E-Based Emulsion is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung CancerCompletedPhase 2Achieve Life SciencesNCT00034164Written as S-8184 Paclitaxel Injectable EmulsionHow we know
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal AdenocarcinomaCompletedPhase 2Achieve Life SciencesNCT00034190Written as S-8184 Paclitaxel Injectable EmulsionHow we know
- Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the UrotheliumCompletedPhase 2Achieve Life SciencesNCT00034177Written as S-8184 Paclitaxel Injectable EmulsionHow we know
- Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian CancerCompletedPhase 2Achieve Life SciencesNCT00034151Written as S-8184 Paclitaxel Injectable EmulsionHow we know